Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Jiangxi Xinsen Pharmaceutical is a Chinese pharmaceutical company headquartered in Fuzhou, Jiangxi Province. Founded in 2001, the company focuses on the development, production, and sale of chemical drugs and Traditional Chinese Medicine (TCM) preparations. Its product portfolio includes a variety of oral solid dosage forms such as tablets, capsules, and granules, targeting therapeutic areas like respiratory health, anti-infectives, and digestive care. The company operates GMP-certified manufacturing facilities and is recognized as a high-tech enterprise within its region. Jiangxi Xinsen primarily serves the domestic Chinese market with a range of essential generic and proprietary medications.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Jiangxi Xinsen.